{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:31:23Z","timestamp":1792798283515,"version":"4.5.0"},"reference-count":224,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajicjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ajic.2023.02.006","type":"journal-article","created":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T19:52:54Z","timestamp":1698263574000},"page":"A22-A34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"S","title":["Emerging infectious diseases, focus on infection prevention, environmental survival and germicide susceptibility: SARS-CoV-2, Mpox, and Candida auris"],"prefix":"10.1016","volume":"51","author":[{"given":"David J.","family":"Weber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Rutala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Sickbert-Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2023.02.006_bib0001","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3201\/eid0102.950201","article-title":"Travel and the emergence of infectious diseases","volume":"1","author":"Wilson","year":"1995","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0002","series-title":"Emerging Infections: Microbial threats to health in the United States","year":"1992"},{"key":"10.1016\/j.ajic.2023.02.006_bib0003","series-title":"Emerging infectious diseases from the global to the local perspective: A summary of a workshop of the Forum on Emerging Infections","year":"2001"},{"key":"10.1016\/j.ajic.2023.02.006_bib0004","unstructured":"World Health Organization. A brief guide to emerging infectious diseases and zoonoses. Accessed November 14, 2022. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/204722\/B5123.pdf?sequence=1&isAllowed=y."},{"key":"10.1016\/j.ajic.2023.02.006_bib0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/1874357901812010131","article-title":"Impact of Emerging, Re-emerging and zoonotic viral infectious diseases, in a virologist's perspective","volume":"12","author":"Kobayashi","year":"2018","journal-title":"Open Virol J"},{"key":"10.1016\/j.ajic.2023.02.006_bib0006","unstructured":"Centers for Disease Control and Prevention. Bioterrorism agents\/diseases. Accessed November 14, 2022. https:\/\/emergency.cdc.gov\/agent\/agentlist-category.asp."},{"key":"10.1016\/j.ajic.2023.02.006_bib0007","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ccc.2013.03.015","article-title":"Biowarfare and bioterrorism","volume":"29","author":"Christian","year":"2013","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.ajic.2023.02.006_bib0008","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1056\/NEJMra1409755","article-title":"Clinical management of potential bioterrorism-related conditions","volume":"372","author":"Adalja","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajic.2023.02.006_bib0009","unstructured":"World Health Organization. WHO publishes list of bacteria for which new antibiotics are urgently needed. Accessed November 14, 2022. https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed."},{"key":"10.1016\/j.ajic.2023.02.006_bib0010","unstructured":"World Health Organization. Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens (8-9 December 2015). Accessed November 13, 2022. https:\/\/cdn.who.int\/media\/docs\/default-source\/blue-print\/2015-workshop-on-prioritization-of-pathogens.pdf?sfvrsn=50b6ddaa_2."},{"key":"10.1016\/j.ajic.2023.02.006_bib0011","unstructured":"World Health Organization. Prioritizing diseases for research and development in emergency contexts (2022). Accessed November 13, 2022. https:\/\/www.who.int\/activities\/prioritizing-diseases-for-research-and-development-in-emergency-contexts."},{"issue":"suppl 5","key":"10.1016\/j.ajic.2023.02.006_bib0012","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.ajic.2015.11.018","volume":"44","author":"Weber","year":"2016","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ajic.2023.02.006_bib0013","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1017\/ice.2020.1427","article-title":"Lessons learned in infection prevention for Ebola virus disease and the coronavirus disease 2019 (COVID-19) pandemic-Principles underlying prevention","volume":"42","author":"Shenoy","year":"2021","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0014","doi-asserted-by":"crossref","first-page":"A29","DOI":"10.1016\/j.ajic.2019.03.004","article-title":"New and emerging infectious diseases (Ebola, Middle Eastern respiratory syndrome coronavirus, carbapenem-resistant Enterobacteriaceae, Candida auris): focus on environmental survival and germicide susceptibility","volume":"47S","author":"Weber","year":"2019","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ajic.2023.02.006_bib0015","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/postgradmedj-2020-138386","article-title":"SARS-CoV-2 and the pandemic of COVID-19","volume":"97","author":"Adil","year":"2021","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ajic.2023.02.006_bib0016","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/MCP.0000000000000774","article-title":"Lethal zoonotic coronavirus infections of humans - comparative phylogenetics, epidemiology, transmission, and clinical features of coronavirus disease 2019, The Middle East respiratory syndrome and severe acute respiratory syndrome","volume":"27","author":"Hui","year":"2021","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.ajic.2023.02.006_bib0017","doi-asserted-by":"crossref","first-page":"e3303","DOI":"10.1002\/jgm.3303","article-title":"COVID-19: virology, biology and novel laboratory diagnosis","volume":"23","author":"Mohamadian","year":"2021","journal-title":"J Gene Med"},{"key":"10.1016\/j.ajic.2023.02.006_bib0018","unstructured":"Johns Hopkins Coronavirus Resource Center. Accessed November 15, 2022. https:\/\/coronavirus.jhu.edu\/map.html."},{"key":"10.1016\/j.ajic.2023.02.006_bib0019","unstructured":"Centers for Disease Control and Prevention. Laboratory-confirmed COVID-19-associated hospitalizations. Accessed November 15, 2022. https:\/\/gis.cdc.gov\/grasp\/covidnet\/covid19_5.html."},{"key":"10.1016\/j.ajic.2023.02.006_bib0020","unstructured":"Ortaliza J, Amin K, Cox C. COVID-19 leading cause of death ranking. Accessed November 15, 2022. https:\/\/www.healthsystemtracker.org\/brief\/covid-19-leading-cause-of-death-ranking\/."},{"key":"10.1016\/j.ajic.2023.02.006_bib0021","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/jamainternmed.2022.2476","article-title":"Leading causes of death in the US during the COVID-19 pandemic, March 2020 to October 2021","volume":"182","author":"Shiels","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ajic.2023.02.006_bib0022","unstructured":"Centers for Disease Control and Prevention. Life expectancy in the U.S. dropped for the second year in a row in 2021. Accessed November 15, 2022. https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2022\/20220831.htm."},{"key":"10.1016\/j.ajic.2023.02.006_bib0023","doi-asserted-by":"crossref","first-page":"n1343","DOI":"10.1136\/bmj.n1343","article-title":"Effect of the covid-19 pandemic in 2020 on life expectancy across populations in the USA and other high income countries: simulations of provisional mortality data","volume":"373","author":"Woolf","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ajic.2023.02.006_bib0024","doi-asserted-by":"crossref","first-page":"16144","DOI":"10.1038\/s41598-021-95565-8","article-title":"More than 50 long-term effects of COVID-19: a systematic review and meta-analysis","volume":"11","author":"Lopez-Leon","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajic.2023.02.006_bib0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.38804","article-title":"Prevalence and correlates of long COVID symptoms among US adults","volume":"5","author":"Perlis","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajic.2023.02.006_bib0026","unstructured":"Centers for Disease Control and Prevention. Post-COVID conditions: information for healthcare providers (22 September 2022). Accessed November 15, 2022. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/clinical-care\/post-covid-conditions.html."},{"key":"10.1016\/j.ajic.2023.02.006_bib0027","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.3390\/ijerph19116865","article-title":"Long-term consequences of COVID-19 at 6 months and above: a systematic review and meta-analysis","volume":"19","author":"Ma","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ajic.2023.02.006_bib0028","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmi.2022.01.014","article-title":"Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis","volume":"28","author":"Alkodaymi","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ajic.2023.02.006_bib0029","first-page":"1","article-title":"Continued increases in the incidence of healthcare-associated infection (HAI) during the second year of the coronavirus disease 2019 (COVID-19) pandemic","volume":"20","author":"Lastinger","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0030","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/cid\/ciac684","article-title":"The disproportionate impact of COVID-19 pandemic on healthcare-associated infections in community hospitals: need for expanding the infectious disease workforce","volume":"76","author":"Advani","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0031","series-title":"COVID-19: U.S. impact on antimicrobial resistance, special report 2022","year":"2022"},{"key":"10.1016\/j.ajic.2023.02.006_bib0032","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ccc.2022.01.005","article-title":"Severe COVID-19 and multisystem inflammatory syndrome in children and adolescents","volume":"38","author":"Blatz","year":"2022","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.ajic.2023.02.006_bib0033","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","article-title":"Long-term cardiovascular outcomes of COVID-19","volume":"28","author":"Xie","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.ajic.2023.02.006_bib0034","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3976","article-title":"Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019","volume":"3","author":"Lai","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajic.2023.02.006_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.114359","article-title":"The mental health impact of contact with COVID-19 patients on healthcare workers in the United States","volume":"308","author":"Hurst","year":"2022","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.ajic.2023.02.006_bib0036","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.comcom.2022.10.013","article-title":"A comprehensive review on variants of SARS-CoVs-2: challenges, solutions and open issues","volume":"197","author":"Deepanshi","year":"2023","journal-title":"Comput Commun"},{"key":"10.1016\/j.ajic.2023.02.006_bib0037","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajic.2023.02.006_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.552909","article-title":"Comparative review of SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza a respiratory viruses","volume":"11","author":"Abdelrahman","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0039","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/v13020202","article-title":"COVID-19: a Review on the novel coronavirus disease evolution, transmission, detection, control and prevention","volume":"13","author":"Sharma","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ajic.2023.02.006_bib0040","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/17512433.2021.1902303","article-title":"Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence","volume":"14","author":"Rahman","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0041","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.it.2020.10.004","article-title":"Mechanisms of SARS-CoV-2 transmission and pathogenesis","volume":"41","author":"Harrison","year":"2020","journal-title":"Trends Immunol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0042","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3349\/ymj.2022.0383","article-title":"SARS-CoV-2 Omicron variant of concern: everything you wanted to know about Omicron but were afraid to ask","volume":"63","author":"Shin","year":"2022","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.ajic.2023.02.006_bib0043","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3390\/vaccines10091538","article-title":"SARS-CoV-2 variants, current vaccines and therapeutic implications for COVID-19","volume":"10","author":"Liang","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ajic.2023.02.006_bib0044","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/M20-0504","article-title":"The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application","volume":"172","author":"Lauer","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajic.2023.02.006_bib0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-039652","article-title":"Incubation period of COVID-19: a rapid systematic review and meta-analysis of observational research","volume":"10","author":"McAloon","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajic.2023.02.006_bib0046","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13643-021-01648-y","article-title":"The incubation period during the pandemic of COVID-19: a systematic review and meta-analysis","volume":"10","author":"Dhouib","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.ajic.2023.02.006_bib0047","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.28008","article-title":"Incubation period of COVID-19 caused by unique SARS-CoV-2 strains: a systematic review and meta-analysis","volume":"5","author":"Wu","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajic.2023.02.006_bib0048","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242128","article-title":"Reproductive number of coronavirus: a systematic review and meta-analysis based on global level evidence","volume":"15","author":"Billah","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ajic.2023.02.006_bib0049","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3390\/v14071482","article-title":"Modeling the impact of vaccination on COVID-19 and its Delta and Omicron variants","volume":"14","author":"Wang","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ajic.2023.02.006_bib0050","unstructured":"Infectious Disease Society of America. IDSA Guidelines on the treatment and management of patients with COVID-19 (updated 21 November 2022). Accessed November 22, 2022. https:\/\/www.idsociety.org\/practice-guideline\/covid-19-guideline-treatment-and-management\/"},{"key":"10.1016\/j.ajic.2023.02.006_bib0051","unstructured":"National Institutes of Health. Coronavirus disease 2019 (COVID-19) treatment guidelines. Accessed November 22, 2022. https:\/\/www.covid19treatmentguidelines.nih.gov\/."},{"key":"10.1016\/j.ajic.2023.02.006_bib0052","unstructured":"National Institutes of Health. Coronavirus disease 2019 (COVID-19) treatment guidelines. Clinical management of adults summary (updated 26 September 2022). Accessed November 22, 2022.https:\/\/www.covid19treatmentguidelines.nih.gov\/management\/clinical-management-of-adults\/clinical-management-of-adults-summary\/?utm_source=site&utm_medium=home&utm_campaign=highlights."},{"key":"10.1016\/j.ajic.2023.02.006_bib0053","unstructured":"National Institutes of Health. Coronavirus disease 2019 (COVID-19) treatment guidelines. Clinical management of children summary (updated 8 August 2022). Accessed November 22, 2022. https:\/\/www.covid19treatmentguidelines.nih.gov\/management\/clinical-management-of-children\/clinical-management-of-children-summary\/?utm_source=site&utm_medium=home&utm_campaign=highlights."},{"key":"10.1016\/j.ajic.2023.02.006_bib0054","unstructured":"Centers for Disease Control and Prevention. COVID-19 treatments and medications (updated 19 October 2022). Accessed November 22, 2022. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/your-health\/treatments-for-severe-illness.html?s_cid=11806:new%20covid%20treatment:sem.ga:p:RG:GM:gen:TTTC:FY23."},{"key":"10.1016\/j.ajic.2023.02.006_bib0055","unstructured":"Centers for Disease Control and Prevention. Stay up to date with COVID-19 vaccines including boosters (updated 1 November 2022). Accessed November 22, 2022. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/stay-up-to-date.html?s_cid=11747:covid%20vaccine%20schedule:sem.ga:p:RG:GM:gen:PTN:FY22."},{"key":"10.1016\/j.ajic.2023.02.006_bib0056","unstructured":"Centers for Disease Control and Prevention. COVID-19 vaccines are effective (updated 29 June 2022). Accessed November 22, 2022. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/effectiveness\/index.html."},{"key":"10.1016\/j.ajic.2023.02.006_bib0057","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.3201\/eid2607.200764","article-title":"COVID-19 outbreak associated with air conditioning in restaurant, Guangzhou, China, 2020","volume":"26","author":"Lu","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0058","doi-asserted-by":"crossref","first-page":"292.e1","DOI":"10.1016\/j.jvoice.2020.12.042","article-title":"COVID-19: impact on the musician and returning to singing; A literature review","volume":"37","author":"Vance","year":"2023","journal-title":"J Voice"},{"key":"10.1016\/j.ajic.2023.02.006_bib0059","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/infdis\/jiaa742","article-title":"Outdoor transmission of SARS-CoV-2 and other respiratory viruses: a systematic review","volume":"223","author":"Bulfone","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0060","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3201\/eid2606.200412","article-title":"Indirect virus transmission in cluster of COVID-19 cases, Wenzhou, China, 2020","volume":"26","author":"Cai","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0061","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1186\/s12889-020-09296-y","article-title":"The evidence of indirect transmission of SARS-CoV-2 reported in Guangzhou, China","volume":"20","author":"Xie","year":"2020","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ajic.2023.02.006_bib0062","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.3390\/microorganisms10112166","article-title":"SARS-CoV-2 as a zooanthroponotic infection: spillbacks, secondary spillovers, and their importance","volume":"10","author":"Pappas","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.ajic.2023.02.006_bib0063","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.35057","article-title":"SARS-CoV-2 transmission from people without COVID-19 symptoms","volume":"4","author":"Johansson","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajic.2023.02.006_bib0064","doi-asserted-by":"crossref","first-page":"e57149","DOI":"10.7554\/eLife.57149","article-title":"Evidence for transmission of COVID-19 prior to symptom onset","volume":"9","author":"Tindale","year":"2020","journal-title":"Elife."},{"key":"10.1016\/j.ajic.2023.02.006_bib0065","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-041240","article-title":"Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data","volume":"11","author":"Casey-Bryars","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajic.2023.02.006_bib0066","first-page":"e3007","article-title":"Systematic review and meta-analyses of superspreading of SARS-CoV-2 infections","volume":"69","author":"Du","year":"2022","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0067","unstructured":"Centers for Disease Control and Prevention. COVID-19: ending isolation and precautions for people with COVID-19: interim guidance (updated 31 August 2022). Accessed November 22, 2022. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/duration-isolation.html."},{"key":"10.1016\/j.ajic.2023.02.006_bib0068","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1128\/AEM.02291-09","article-title":"Effects of air temperature and relative humidity on coronavirus survival on surfaces","volume":"76","author":"Casanova","year":"2010","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0069","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1086\/652452","article-title":"Coronavirus survival on healthcare personal protective equipment","volume":"31","author":"Casanova","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0070","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ajic.2009.03.012","article-title":"The antiviral action of common household disinfectants and antiseptics against murine hepatitis virus, a potential surrogate for SARS coronavirus","volume":"37","author":"Dellanno","year":"2009","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ajic.2023.02.006_bib0071","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ajic.2010.08.011","article-title":"Inactivation of surrogate coronaviruses on hard surfaces by health care germicides","volume":"39","author":"Hulkower","year":"2011","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ajic.2023.02.006_bib0072","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.3390\/v4113044","article-title":"Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies","volume":"4","author":"Geller","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.ajic.2023.02.006_bib0073","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1053\/jhin.2000.0795","article-title":"Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces: a possible source of hospital-acquired infections","volume":"46","author":"Sizun","year":"2000","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ajic.2023.02.006_bib0074","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jhin.2015.08.027","article-title":"Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination","volume":"92","author":"Otter","year":"2016","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ajic.2023.02.006_bib0075","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1021\/acs.est.0c05651","article-title":"A systematic review of surface contamination, stability, and disinfection data on SARS-CoV-2 (Through July 10, 2020)","volume":"55","author":"Bedrosian","year":"2021","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2021.146191","article-title":"A systematic review of human coronaviruses survival on environmental surfaces","volume":"778","author":"Marzoli","year":"2021","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.ajic.2023.02.006_bib0077","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2020.110559","article-title":"Contamination of inert surfaces by SARS-CoV-2: persistence, stability and infectivity. A review","volume":"193","author":"Marqu\u00e8s","year":"2021","journal-title":"Environ Res"},{"key":"10.1016\/j.ajic.2023.02.006_bib0078","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/1937586721991535","article-title":"SARS-CoV-2 Viability on 16 common indoor surface finish materials","volume":"14","author":"Ronca","year":"2021","journal-title":"HERD"},{"key":"10.1016\/j.ajic.2023.02.006_bib0079","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMc2004973","article-title":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1","volume":"382","author":"van Doremalen","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajic.2023.02.006_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263025","article-title":"Presence and stability of SARS-CoV-2 on environmental currency and money cards in Utah reveals a lack of live virus","volume":"17","author":"Newey","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ajic.2023.02.006_bib0081","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/cid\/ciaa1467","article-title":"Role of the healthcare surface environment in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) transmission and potential control measures","volume":"72","author":"Kanamori","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0082","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.3390\/ijerph18073824","article-title":"Environmental detection of SARS-CoV-2 virus RNA in health facilities in Brazil and a systematic review on contamination sources","volume":"18","author":"Vicente","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ajic.2023.02.006_bib0083","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2021.149231","article-title":"Surface contamination with SARS-CoV-2: a systematic review","volume":"798","author":"Gon\u00e7alves","year":"2021","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.ajic.2023.02.006_bib0084","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1093\/cid\/ciac023","article-title":"Severe acute respiratory syndrome coronavirus 2 environmental contamination in hospital rooms is uncommon using viral culture techniques","volume":"75","author":"Weber","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0085","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1093\/cid\/ciac023","article-title":"Severe acute respiratory syndrome coronavirus 2 environmental contamination in hospital rooms is uncommon using viral culture techniques","volume":"75","author":"Warren","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0086","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1017\/S0950268820002319","article-title":"Alcohol-based hand sanitizers as first line of defense against SARS-CoV-2: a review of biology, chemistry and formulations","volume":"148","author":"Singh","year":"2020","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ajic.2023.02.006_bib0087","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jhin.2020.01.022","article-title":"Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents","volume":"104","author":"Kampf","year":"2020","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ajic.2023.02.006_bib0088","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9342748","article-title":"Viral inactivation with emphasis on SARS-CoV-2 using physical and chemical d isinfectants","volume":"2021","author":"Fadaei","year":"2021","journal-title":"Scientific World Journal"},{"key":"10.1016\/j.ajic.2023.02.006_bib0089","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1515\/reveh-2020-0075","article-title":"Environmental disinfection against COVID-19 in different areas of health care facilities: a review","volume":"36","author":"Sharafi","year":"2020","journal-title":"Rev Environ Health"},{"key":"10.1016\/j.ajic.2023.02.006_bib0090","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.3390\/v14081721","article-title":"Disinfectants against SARS-CoV-2: a review","volume":"14","author":"Xiao","year":"2022","journal-title":"Viruses."},{"key":"10.1016\/j.ajic.2023.02.006_bib0091","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhin.2021.07.014","article-title":"Disinfection methods against SARS-CoV-2: a systematic review","volume":"119","author":"Viana Martins","year":"2022","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ajic.2023.02.006_bib0092","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jhin.2022.09.011","article-title":"Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2","volume":"131","author":"Lee","year":"2022","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ajic.2023.02.006_bib0093","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1017\/ice.2021.481","article-title":"Continuously active disinfectant inactivates severe acute respiratory coronavirus virus 2 (SARS-CoV-2) and human coronavirus 229E two days after the disinfectant was applied and following wear exposures","volume":"44","author":"Rutala","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0094","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1017\/ice.2020.327","article-title":"Universal pandemic precautions-An idea ripe for the times","volume":"41","author":"Weber","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0095","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.ajic.2021.08.009","article-title":"Building a personal protective equipment monitor team as part of a comprehensive COVID-19 prevention strategy","volume":"49","author":"Summerlin-Long","year":"2021","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ajic.2023.02.006_bib0096","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.cmi.2021.05.036","article-title":"The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis","volume":"27","author":"Kay\u0131","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ajic.2023.02.006_bib0097","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.1283","article-title":"Risk factors associated with SARS-CoV-2 seropositivity among US health care personnel","volume":"4","author":"Jacob","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajic.2023.02.006_bib0098","doi-asserted-by":"crossref","DOI":"10.1063\/5.0016018","article-title":"Visualizing the effectiveness of face masks in obstructing respiratory jets","volume":"32","author":"Verma","year":"2020","journal-title":"Phys Fluids (1994)"},{"key":"10.1016\/j.ajic.2023.02.006_bib0099","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41591-020-0843-2","article-title":"Respiratory virus shedding in exhaled breath and efficacy of face masks","volume":"26","author":"Leung","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.ajic.2023.02.006_bib0100","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1001\/jamainternmed.2020.4221","article-title":"Filtration efficiency of hospital face mask alternatives available for use during the COVID-19 pandemic","volume":"180","author":"Sickbert-Bennett","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ajic.2023.02.006_bib0101","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/jamainternmed.2020.8168","article-title":"Evaluation of cloth masks and modified procedure masks as personal protective equipment for the public during the COVID-19 pandemic","volume":"181","author":"Clapp","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ajic.2023.02.006_bib0102","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1001\/jamainternmed.2021.2033","article-title":"Fitted filtration efficiency of double masking during the COVID-19 pandemic","volume":"181","author":"Sickbert-Bennett","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ajic.2023.02.006_bib0103","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jhin.2020.03.036","article-title":"Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong","volume":"105","author":"Wong","year":"2020","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ajic.2023.02.006_bib0104","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/S0140-6736(20)31142-9","article-title":"Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis","volume":"395","author":"Chu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ajic.2023.02.006_bib0105","doi-asserted-by":"crossref","first-page":"W108","DOI":"10.7326\/L22-0272","article-title":"Update Alert 8: masks for prevention of respiratory virus infections, including SARS-CoV-2, in health care and community settings","volume":"175","author":"Chou","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajic.2023.02.006_bib0106","article-title":"Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis","volume":"375","author":"Talic","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ajic.2023.02.006_bib0107","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1017\/ice.2021.322","article-title":"Multisociety statement on coronavirus disease 2019 (COVID-19) vaccination as a condition of employment for healthcare personnel","volume":"43","author":"Weber","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0108","unstructured":"U.S. Environmental Protection Agency. List N: disinfectants for coronavirus (COVID-19). Accessed November 23, 2022. https:\/\/www.epa.gov\/coronavirus\/about-list-n-disinfectants-coronavirus-covid-19-0."},{"key":"10.1016\/j.ajic.2023.02.006_bib0109","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.3390\/v7042168","article-title":"A phylogeographic investigation of African monkeypox","volume":"7","author":"Nakazawa","year":"2015","journal-title":"Viruses."},{"key":"10.1016\/j.ajic.2023.02.006_bib0110","unstructured":"Centers for Disease Control and Prevention. Smallpox & other orthopoxvirus-associated infections. Accessed November 12, 2022. https:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2020\/travel-related-infectious-diseases\/smallpox-and-other-orthopoxvirus-associated-infections."},{"key":"10.1016\/j.ajic.2023.02.006_bib0111","unstructured":"Centers for Disease Control and Prevention. About Monkeypox. Accessed November 12, 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/about\/index.html."},{"key":"10.1016\/j.ajic.2023.02.006_bib0112","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1473-3099(03)00856-9","article-title":"Human monkeypox: an emerging zoonosis","volume":"4","author":"Di Giulio","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"suppl 4","key":"10.1016\/j.ajic.2023.02.006_bib0113","doi-asserted-by":"crossref","first-page":"D54","DOI":"10.1016\/j.vaccine.2011.04.014","article-title":"Status of human monkeypox: clinical disease, epidemiology and research","volume":"29","author":"Damon","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ajic.2023.02.006_bib0114","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/cid\/cit703","article-title":"Human monkeypox","volume":"58","author":"McCollum","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0115","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijid.2018.11.008","article-title":"Monkeypox - Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era","volume":"78","author":"Petersen","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0116","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.idc.2019.03.001","article-title":"Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention","volume":"33","author":"Petersen","year":"2019","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ajic.2023.02.006_bib0117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007791","article-title":"A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy","volume":"13","author":"Beer","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0118","doi-asserted-by":"crossref","first-page":"ofac310","DOI":"10.1093\/ofid\/ofac310","article-title":"Monkeypox: a contemporary review for healthcare professionals","volume":"9","author":"Titanji","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0119","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","article-title":"Clinical features and management of human monkeypox: a retrospective observational study in the UK","volume":"22","author":"Adler","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010141","article-title":"The changing epidemiology of human monkeypox-A potential threat? A systematic review","volume":"16","author":"Bunge","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0121","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3390\/v12111257","article-title":"Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution","volume":"12","author":"Alakunle","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ajic.2023.02.006_bib0122","doi-asserted-by":"crossref","first-page":"306","DOI":"10.15585\/mmwr.mm6710a5","article-title":"Emergence of monkeypox - West and Central Africa, 1970-2017","volume":"67","author":"Durski","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajic.2023.02.006_bib0123","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/ije\/17.3.643","article-title":"The transmission potential of monkeypox virus in human populations","volume":"17","author":"Fine","year":"1988","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0124","unstructured":"Centers for Disease Control and Prevention. Monkeypox: past U.S. cases and outbreaks. Accessed November 11, 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/outbreak\/us-outbreaks.html."},{"key":"10.1016\/j.ajic.2023.02.006_bib0125","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1086\/505880","article-title":"Clinical manifestations of human monkeypox influenced by route of infection","volume":"194","author":"Reynolds","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0126","first-page":"642","article-title":"Update: multistate outbreak of monkeypox - Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003","volume":"52","year":"2003","journal-title":"MMWR"},{"key":"10.1016\/j.ajic.2023.02.006_bib0127","doi-asserted-by":"crossref","first-page":"509","DOI":"10.15585\/mmwr.mm7114a1","article-title":"Monkeypox in a traveler returning from Nigeria - Dallas, Texas, July 2021","volume":"71","author":"Rao","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajic.2023.02.006_bib0128","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.15585\/mmwr.mm7132e3","article-title":"Epidemiologic and clinical characteristics of monkeypox cases - United States, May 17-July 22, 2022","volume":"71","author":"Philpott","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajic.2023.02.006_bib0129","unstructured":"Centers for Disease Control and Prevention. 2022 Outbreak Cases and Data. Accessed November 12, 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/response\/2022\/index.html."},{"key":"10.1016\/j.ajic.2023.02.006_bib0130","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.3390\/jcm11216388","article-title":"Genetic variability of the monkeypox virus clade IIb B.1","volume":"11","author":"Scarpa","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajic.2023.02.006_bib0131","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.24.2200448","article-title":"Estimated incubation period for monkeypox cases confirmed in the Netherlands, May 2022","volume":"27","author":"Miura","year":"2022","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ajic.2023.02.006_bib0132","doi-asserted-by":"crossref","first-page":"taac105","DOI":"10.1093\/jtm\/taac105","article-title":"Serial intervals and incubation periods of the monkeypox virus clades","volume":"29","author":"Wang","year":"2022","journal-title":"J Travel Med"},{"key":"10.1016\/j.ajic.2023.02.006_bib0133","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taac099","article-title":"Reproduction number of monkeypox in the early stage of the 2022 multi-country outbreak","volume":"29","author":"Du","year":"2022","journal-title":"J Travel Med"},{"key":"10.1016\/j.ajic.2023.02.006_bib0134","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022","volume":"387","author":"Thornhill","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajic.2023.02.006_bib0135","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12941-022-00527-1","article-title":"Clinical features, hospitalisation and deaths associated with monkeypox: a systematic review and meta-analysis","volume":"21","author":"Benites-Zapata","year":"2022","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.ajic.2023.02.006_bib0136","doi-asserted-by":"crossref","first-page":"734","DOI":"10.15585\/mmwr.mm7122e1","article-title":"Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: recommendations of the Advisory Committee on Immunization Practices - United States, 2022","volume":"71","author":"Rao","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajic.2023.02.006_bib0137","unstructured":"Centers for Disease Control and Prevention. MPOX: interim clinical considerations for use of JYNNEOS and ACAM2000 vaccines during the 2022 U.S. monkeypox outbreak (updated 19 October 2022). Accesssed November 29, 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/vaccines\/vaccine-considerations.html."},{"key":"10.1016\/j.ajic.2023.02.006_bib0138","unstructured":"Centers for Disease Control and Prevention. MPOX: treatment information for healthcare professionals (updated 31 October 2022). Accesssed November 29, 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/treatment.html."},{"key":"10.1016\/j.ajic.2023.02.006_bib0139","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3201\/eid2206.150579","article-title":"Extended human-to-human transmission during a monkeypox outbreak in the Democratic Republic of the Congo","volume":"22","author":"Nolen","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0140","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3201\/eid2604.191164","article-title":"human-to-human transmission of monkeypox virus, United Kingdom, October 2018","volume":"26","author":"Vaughan","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0141","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(22)01487-8","article-title":"Evidence of human-to-dog transmission of monkeypox virus","volume":"400","author":"Seang","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ajic.2023.02.006_bib0142","doi-asserted-by":"crossref","first-page":"ofx168","DOI":"10.1093\/ofid\/ofx168","article-title":"A Nosocomial outbreak of human monkeypox in the Central African Republic","volume":"4","author":"Nakoune","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0143","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S1473-3099(19)30294-4","article-title":"Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report","volume":"19","author":"Yinka-Ogunleye","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0144","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214229","article-title":"The 2017 human monkeypox outbreak in Nigeria-Report of outbreak experience and response in the Niger Delta University Teaching Hospital, Bayelsa State, Nigeria","volume":"14","author":"Ogoina","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ajic.2023.02.006_bib0145","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.3201\/eid2811.221323","article-title":"Monkeypox Virus Transmission to healthcare worker through needlestick injury","volume":"28","author":"Carvalho","year":"2022","journal-title":"Brazil. Emerg Infect Dis."},{"key":"10.1016\/j.ajic.2023.02.006_bib0146","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3201\/eid2812.221374","article-title":"Monkeypox after Occupational needlestick injury from pustule","volume":"28","author":"Caldas","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0147","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.15585\/mmwr.mm7142e2","article-title":"Monkeypox virus infection resulting from an occupational needlestick - Florida, 2022","volume":"71","author":"Mendoza","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajic.2023.02.006_bib0148","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.15585\/mmwr.mm7134e1","article-title":"High-contact object and surface contamination in a household of persons with monkeypox virus infection - Utah, June 2022","volume":"71","author":"Pfeiffer","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajic.2023.02.006_bib0149","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.3201\/eid2810.221047","article-title":"Environmental persistence of monkeypox virus on surfaces in household of person with travel-associated infection, Dallas, Texas, USA, 2021","volume":"28","author":"Morgan","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0150","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1111\/1462-2920.16129","article-title":"Infection-competent monkeypox virus contamination identified in domestic settings following an imported case of monkeypox into the UK","volume":"24","author":"Atkinson","year":"2022","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0151","doi-asserted-by":"crossref","first-page":"e904","DOI":"10.1016\/S2666-5247(22)00257-9","article-title":"Air and surface sampling for monkeypox virus in a UK hospital: an observational study","volume":"3","author":"Gould","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ajic.2023.02.006_bib0152","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.26.2200477","article-title":"Evidence of surface contamination in hospital rooms occupied by patients infected with monkeypox, Germany, June 2022","volume":"27","author":"N\u00f6rz","year":"2022","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ajic.2023.02.006_bib0153","doi-asserted-by":"crossref","unstructured":"Marimuthu K, Wong JCC, Lim PL, et al. Viable Monkeypox virus in the environment of a patient room. Accessed November 12, 2022. https:\/\/www.medrxiv.org\/content\/10.1101\/2022.09.15.22280012v1.full.pdf.","DOI":"10.1101\/2022.09.15.22280012"},{"key":"10.1016\/j.ajic.2023.02.006_bib0154","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/cid\/ciac654","article-title":"Environmental testing of Surfaces in the room of a patient with monkeypox","volume":"76","author":"Muller","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0155","first-page":"710","article-title":"Effect of temperature and relative humidity on variola virus in crusts","volume":"54","author":"Huq","year":"1976","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ajic.2023.02.006_bib0156","first-page":"247","article-title":"Survival of variola virus in raw cotton","volume":"16","author":"MacCallum","year":"1957","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ajic.2023.02.006_bib0157","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4269\/ajtmh.2011.11-0144","article-title":"Susceptibility of vaccinia virus to chemical disinfectants","volume":"85","author":"de Oliveira","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ajic.2023.02.006_bib0158","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/aem.32.2.209-212.1976","article-title":"Effect of disinfectants on variola virus in cell culture","volume":"32","author":"Tanabe","year":"1976","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0159","unstructured":"Centers for Disease Control and Prevention. Infection Prevention and Control of Monkeypox in healthcare settings (31 October 2022). Accessed November13, 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/infection-control-healthcare.html."},{"key":"10.1016\/j.ajic.2023.02.006_bib0160","unstructured":"World Health Organization. Monkeypox (19 May 2022). Accessed November13, 2022. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/monkeypox."},{"key":"10.1016\/j.ajic.2023.02.006_bib0161","unstructured":"UK Health Security Agency. Principles for monkeypox control in the UK: 4 nations consensus statement (3 November 2022). Accessed November13, 2022. https:\/\/www.gov.uk\/government\/publications\/principles-for-monkeypox-control-in-the-uk-4-nations-consensus-statement\/principles-for-monkeypox-control-in-the-uk-4-nations-consensus-statement."},{"key":"10.1016\/j.ajic.2023.02.006_bib0162","unstructured":"Environmental Protection Agency. Disinfectants for emerging viral pathogens (EVPs): List Q. Accessed November13, 2022. https:\/\/www.epa.gov\/pesticide-registration\/disinfectants-emerging-viral-pathogens-evps-list-q."},{"key":"10.1016\/j.ajic.2023.02.006_bib0163","unstructured":"Centers for Disease Control and Prevention. Candida auris. Accessed November 27, 2022. https:\/\/www.cdc.gov\/fungal\/candida-auris\/index.html."},{"key":"10.1016\/j.ajic.2023.02.006_bib0164","unstructured":"Centers for Disease Control and Prevention. Candida auris: general information about Candida auris. Accessed November 27, 2022. https:\/\/www.cdc.gov\/fungal\/candida-auris\/candida-auris-qanda.html."},{"key":"10.1016\/j.ajic.2023.02.006_bib0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1348-0421.2008.00083.x","article-title":"Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital","volume":"53","author":"Satoh","year":"2009","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0166","unstructured":"Centers for Disease Control and Prevention. Candida auris: tracking Candida auris. Accessed November 27, 2022. https:\/\/www.cdc.gov\/fungal\/candida-auris\/tracking-c-auris.html."},{"key":"10.1016\/j.ajic.2023.02.006_bib0167","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S1473-3099(18)30597-8","article-title":"Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey","volume":"18","author":"Chow","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0168","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0169","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03364-19","article-title":"Tracing the evolutionary history and global expansion of Candida auris using population genomic analyses","volume":"11","author":"Chow","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.ajic.2023.02.006_bib0170","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/jof5030058","article-title":"On the origins of a species: What might explain the rise of Candida auris?","volume":"5","author":"Jackson","year":"2019","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ajic.2023.02.006_bib0171","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/infdis\/jix597","article-title":"The Candida auris alert: facts and perspectives","volume":"217","author":"Lamoth","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0172","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/cid\/cix744","article-title":"Approach to the investigation and management of patients with Candida auris, an emerging multidrug-resistant yeast","volume":"66","author":"Tsay","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0173","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/s41564-022-01172-2","article-title":"COVID-19-associated fungal infections","volume":"7","author":"Hoenigl","year":"2022","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0174","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/diseases10030058","article-title":"The menace of Candida auris epidemic amidst the COVID-19 pandemic: a systematic review","volume":"10","author":"Najeeb","year":"2022","journal-title":"Diseases"},{"key":"10.1016\/j.ajic.2023.02.006_bib0175","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/myc.13471","article-title":"Global prevalence and subgroup analyses of coronavirus disease (COVID-19) associated Candida auris infections (CACa): a systematic review and meta-analysis","volume":"65","author":"Vaseghi","year":"2022","journal-title":"Mycoses"},{"key":"10.1016\/j.ajic.2023.02.006_bib0176","article-title":"Candida auris Incident Management Team, Manuel R, Brown CS. Candida auris: a review of the literature","volume":"31","author":"Jeffery-Smith","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ajic.2023.02.006_bib0177","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3390\/antibiotics9110778","article-title":"Candida auris: an overview of how to screen, detect, test and control this emerging pathogen","volume":"9","author":"Fasciana","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ajic.2023.02.006_bib0178","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s10096-020-03886-9","article-title":"A decade after the emergence of Candida auris: what do we know?","volume":"39","author":"ElBaradei","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0179","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5858\/arpa.2018-0508-RA","article-title":"Candida auris: an emerging yeast pathogen posing distinct challenges for laboratory diagnostics, treatment, and infection prevention","volume":"144","author":"Hata","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ajic.2023.02.006_bib0180","doi-asserted-by":"crossref","first-page":"ftaa034","DOI":"10.1093\/femspd\/ftaa034","article-title":"Candida auris: a fungus with identity crisis","volume":"78","author":"Vila","year":"2020","journal-title":"Pathog Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0181","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.3390\/ijms22094470","article-title":"Candida auris: a quick review on identification, current treatments, and challenges","volume":"22","author":"\u010cern\u00e1kov\u00e1","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajic.2023.02.006_bib0182","doi-asserted-by":"crossref","first-page":"441","DOI":"10.18683\/germs.2021.1281","article-title":"Candida auris and other phylogenetically related species - a mini-review of the literature","volume":"11","author":"Ciurea","year":"2021","journal-title":"Germs"},{"key":"10.1016\/j.ajic.2023.02.006_bib0183","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.3390\/microorganisms9102177","article-title":"What do we know about Candida auris? State of the art, knowledge gaps, and future directions","volume":"9","author":"Garcia-Bustos","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.ajic.2023.02.006_bib0184","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001318","article-title":"On the emergence, spread and resistance of Candida auris: host, pathogen and environmental tipping points","volume":"70","author":"Chakrabarti","year":"2021","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0185","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3947\/ic.2022.0008","article-title":"Candida auris: an overview of the emerging drug-resistant fungal infection","volume":"54","author":"Sanyaolu","year":"2022","journal-title":"Infect Chemother"},{"key":"10.1016\/j.ajic.2023.02.006_bib0186","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/jof7100878","article-title":"International multicentre study of Candida auris infections","volume":"7","author":"Pandya","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ajic.2023.02.006_bib0187","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.15585\/mmwr.mm6544e1","article-title":"Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus - United States, May 2013-August 2016","volume":"65","author":"Vallabhaneni","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajic.2023.02.006_bib0188","doi-asserted-by":"crossref","first-page":"514","DOI":"10.15585\/mmwr.mm6619a7","article-title":"Notes from the field: ongoing transmission of Candida auris in health care facilities - United States, June 2016-May 2017","volume":"66","author":"Tsay","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajic.2023.02.006_bib0189","doi-asserted-by":"crossref","first-page":"6","DOI":"10.15585\/mmwr.mm6901a2","article-title":"Candida auris isolates resistant to three classes of antifungal medications - New York, 2019","volume":"69","author":"Ostrowsky","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajic.2023.02.006_bib0190","doi-asserted-by":"crossref","first-page":"56","DOI":"10.15585\/mmwr.mm7002e3","article-title":"Candida auris outbreak in a COVID-19 specialty care unit - Florida, July-August 2020","volume":"70","author":"Prestel","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajic.2023.02.006_bib0191","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.15585\/mmwr.mm7029a2","article-title":"Notes from the Field: transmission of pan-resistant and echinocandin-resistant Candida auris in health care facilities - Texas and the District of Columbia, January-April 2021","volume":"70","author":"Lyman","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajic.2023.02.006_bib0192","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/cid\/ciab327","article-title":"Positive correlation between Candida auris skin-colonization burden and environmental contamination at a ventilator-capable skilled nursing facility in Chicago","volume":"73","author":"Sexton","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0193","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jhin.2017.09.009","article-title":"Controlling a possible outbreak of Candida auris infection: lessons learnt from multiple interventions","volume":"97","author":"Biswal","year":"2017","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ajic.2023.02.006_bib0194","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1017\/ice.2017.127","article-title":"Environmental surfaces in healthcare facilities are a potential source for transmission of Candida auris and other Candida species","volume":"38","author":"Piedrahita","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0195","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1128\/JCM.00921-17","article-title":"Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface","volume":"55","author":"Welsh","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0196","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3389\/fmicb.2018.00726","article-title":"Candida auris: disinfectants and implications for infection control","volume":"9","author":"Ku","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0197","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001548","article-title":"Emerging strategies for environmental decontamination of the nosocomial fungal pathogen Candida auris","volume":"71","author":"Bandara","year":"2022","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0198","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1017\/ice.2019.1","article-title":"Susceptibility of Candida auris and Candida albicans to 21 germicides used in healthcare facilities","volume":"40","author":"Rutala","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0199","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1017\/ice.2017.162","article-title":"Effectiveness ofdDisinfectants against Candida auris and other Candida species","volume":"38","author":"Cadnum","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0200","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhin.2017.08.019","article-title":"Yeasticidal activity of chemical disinfectants and antiseptics against Candida auris","volume":"97","author":"Moore","year":"2017","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ajic.2023.02.006_bib0201","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/myc.12699","article-title":"In vitro efficacy of disinfectants utilized for skin decolonization and environmental decontamination during a hospital outbreak with Candida auris","volume":"60","author":"Abdolrasouli","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.ajic.2023.02.006_bib0202","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1017\/ice.2020.278","article-title":"Evaluation of nine surface disinfectants against Candida auris using a quantitative disk carrier method: EPA SOP-MB-35","volume":"41","author":"Sexton","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0203","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jhin.2020.05.026","article-title":"Investigation of the susceptibility of Candida auris and Candida albicans to chemical disinfectants using European Standards EN 13624 and EN 16615","volume":"105","author":"M\u00fcller","year":"2020","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ajic.2023.02.006_bib0204","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1017\/ice.2019.260","article-title":"Antimicrobial activity of a continuously active disinfectant against healthcare pathogens","volume":"40","author":"Rutala","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0205","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/mmy\/myz127","article-title":"The environmental stress sensitivities of pathogenic Candida species, including Candida auris, and implications for their spread in the hospital setting","volume":"58","author":"Heaney","year":"2020","journal-title":"Med Mycol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0206","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1017\/ice.2017.239","article-title":"Relative resistance of the emerging fungal pathogen Candida auris and Other Candida species to killing by ultraviolet light","volume":"39","author":"Cadnum","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0207","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/myc.12903","article-title":"Killing of Candida auris by UV-C: Importance of exposure time and distance","volume":"62","author":"de Groot","year":"2019","journal-title":"Mycoses"},{"key":"10.1016\/j.ajic.2023.02.006_bib0208","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/s12879-019-4137-6","article-title":"The efficacy of pulsed-xenon ultraviolet light technology on Candida auris","volume":"19","author":"Maslo","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ajic.2023.02.006_bib0209","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ajic.2019.08.003","article-title":"Efficacy of an ultraviolet-A lighting system for continuous decontamination of health care-associated pathogens on surfaces","volume":"48","author":"Livingston","year":"2020","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ajic.2023.02.006_bib0210","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1017\/ice.2020.410","article-title":"Clade-specific variation in susceptibility of Candida auris to broad-spectrum ultraviolet C light (UV-C)","volume":"41","author":"Chatterjee","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0211","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1017\/ice.2021.206","article-title":"Efficacy of relatively low-cost ultraviolet-C light devices against Candida auris","volume":"43","author":"Pearlmutter","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0212","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13756-021-00945-4","article-title":"The use of a UV-C disinfection robot in the routine cleaning process: a field study in an Academic hospital","volume":"10","author":"Astrid","year":"2021","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.ajic.2023.02.006_bib0213","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jhin.2021.12.004","article-title":"Effectiveness of ultraviolet-C vs aerosolized hydrogen peroxide in ICU terminal disinfection","volume":"121","author":"Kelly","year":"2022","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ajic.2023.02.006_bib0214","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1017\/ice.2021.214","article-title":"Inactivation of Candida auris and Candida albicans by ultraviolet-C","volume":"43","author":"Rutala","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2023.02.006_bib0215","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/jof5040111","article-title":"Candida auris: a review of recommendations for detection and control in healthcare settings","volume":"5","author":"Caceres","year":"2019","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ajic.2023.02.006_bib0216","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijantimicag.2019.08.013","article-title":"Control of Candida auris in healthcare institutions: outcome of an International Society for Antimicrobial Chemotherapy expert meeting","volume":"54","author":"Kenters","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ajic.2023.02.006_bib0217","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/imj.14612","article-title":"Diagnosis, management and prevention of Candida auris in hospitals: position statement of the Australasian Society for Infectious Diseases","volume":"49","author":"Ong","year":"2019","journal-title":"Intern Med J"},{"key":"10.1016\/j.ajic.2023.02.006_bib0218","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3390\/antibiotics9110778","article-title":"Candida auris: an Overview of how to screen, detect, test and control this emerging pathogen","volume":"9","author":"Fasciana","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ajic.2023.02.006_bib0219","doi-asserted-by":"crossref","first-page":"w20297","DOI":"10.4414\/smw.2020.20297","article-title":"Candida auris - recommendations on infection prevention and control measures in Switzerland","volume":"150","author":"Vuichard-Gysin","year":"2020","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.ajic.2023.02.006_bib0220","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/myc.13445","article-title":"Expert recommendations for prevention and management of Candida auris transmission","volume":"65","author":"Aldejohann","year":"2022","journal-title":"Mycoses"},{"key":"10.1016\/j.ajic.2023.02.006_bib0221","unstructured":"Centers for Disease Control and Prevention. Candida auris: infection prevention and control for Candida auris. Accessed November 29, 2022. https:\/\/www.cdc.gov\/fungal\/candida-auris\/c-auris-infection-control.html."},{"key":"10.1016\/j.ajic.2023.02.006_bib0222","unstructured":"Centers for Disease Control and Prevention. Candida auris: screening for Candida auris colonization. Accessed November 29, 2022. https:\/\/www.cdc.gov\/fungal\/candida-auris\/c-auris-screening.html."},{"key":"10.1016\/j.ajic.2023.02.006_bib0223","unstructured":"Centers for Disease Control and Prevention. Candida auris: surveillance for Candida auris. Accessed November 29, 2022. https:\/\/www.cdc.gov\/fungal\/candida-auris\/c-auris-surveillance.html."},{"key":"10.1016\/j.ajic.2023.02.006_bib0224","unstructured":"Environmental Protection Agency. List P: Antimicrobial Products Registered with EPA for Claims against Candida auris. Accessed November 29, 2022. https:\/\/www.epa.gov\/pesticide-registration\/list-p-antimicrobial-products-registered-epa-claims-against-candida-auris."}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655323000779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655323000779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T06:36:21Z","timestamp":1759300581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196655323000779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":224,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0196655323000779"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2023.02.006","relation":{},"ISSN":["0196-6553"],"issn-type":[{"value":"0196-6553","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging infectious diseases, focus on infection prevention, environmental survival and germicide susceptibility: SARS-CoV-2, Mpox, and Candida auris","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2023.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}